electroCore, Inc.

NASDAQ:ECOR

Medical - Devices

Healthcare
$7.71 -5.70%

-$0.50 today

Market cap
$71.13M
Beta
0.87
P/E (TTM)
-4.8
EPS (TTM)
-$1.72
52W Low $4.16High $10.50

Volume 0.06M

Average 0.11M

ECOR EPS (Diluted)

Earnings per share assuming conversion of dilutive securities such as options and convertible instruments.

electroCore, Inc.NASDAQ: ECOR

EPS (Diluted) · Q1 FY2026 · quarter ended Mar 2026

EPS (Diluted) remains negative

Q1 FY2026 EPS (Diluted) was -$0.59, compared with -$0.47 a year earlier. Trailing-twelve-month EPS (Diluted) was -$1.81.

Context

  • EPS (Diluted) grew in size in 1 of the last 3 fiscal years.

What to watch

Whether EPS (Diluted) reaches the consensus estimate from 4 analysts of -$1.38 (+16.6%) for the fiscal year ending Dec 2026, a step up from the -3.8% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-$0.59-55.3% QoQ
Last fiscal yearDec 2025
-$1.65-3.8% YoY
LTMMar 2026
-$1.81-13.8% YoY
EPS (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-25.5%+4.1%+29.7 pp
1 year-3.8%+16.6%+20.4 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EPS (Diluted) history

USD · from the income statement

Latest · FY2025
(1.65) USD
Year-over-year change
-3.8%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EPS (Diluted) vs competitors

How ECOR compares with its peers on the latest reported figures

  • ECOR's LTM Mar 2026 EPS (Diluted) of -$1.81 is the 4th highest of the 6 companies compared; the peer median is -$0.68.
  • Its year-over-year change of -13.8% is the 5th highest of 6, against a peer median of +17.3%.
ECOR Competitors Peer median
EPS (Diluted) for ECOR and competitors
Company Period LTM YoY 3-year CAGR
RNXTRenovoRx, Inc.LTM Mar 2026-$0.34 +17.3%—
MYOMyomo, Inc.LTM Mar 2026-$0.36 -147.2%—
MAIAMAIA Biotechnology, Inc.LTM Mar 2026-$0.68 +15.6%—
ECORelectroCore, Inc.LTM Mar 2026-$1.81 -13.8%—
PYPDPolyPid Ltd.LTM Mar 2026-$1.91 +55.6%—
HYPDHyperion DeFi, Inc.LTM Jun 2026-$3.22 +93.1%—
Peer median (excluding ECOR) -$0.68+17.3%—

Competitors are the stored peer set for ECOR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue5.45M8.59M16.03M25.18M32.03M
Cost of Revenue1.39M1.62M2.8M3.79M4.24M
Gross Profit4.07M6.98M13.23M21.4M27.79M
Gross Margin74.6%81.2%82.5%85.0%86.8%
Research & Development2.54M5.52M5.32M2.36M2.74M
Selling, General & Admin21.57M24.33M26.71M31.2M38.21M
Operating Expenses24.11M29.85M32.03M33.56M40.94M
Depreciation & Amortization382K596K1.26M1.26M1.68M
EBITDA(17.69M)(22M)(17.76M)(10.72M)(11.7M)
EBITDA Margin-324.5%-256.0%-110.8%-42.6%-36.5%
Operating Income(20.04M)(22.87M)(18.81M)(12.16M)(13.15M)
Operating Margin-367.7%-266.2%-117.3%-48.3%-41.1%
Interest Income11K287K433K572K298K
Interest Expense0000590K
Other Income / Expenses1.97M281K(215K)183K(810K)
Income Before Tax(18.07M)(22.59M)(19.02M)(11.98M)(13.96M)
Pre-Tax Margin-331.5%-263.0%-118.7%-47.6%-43.6%
Income Tax Expense(851K)(431K)(186K)(93K)3K
Net Income(17.22M)(22.16M)(18.83M)(11.89M)(13.97M)
Net Margin-315.9%-257.9%-117.5%-47.2%-43.6%
EPS (Basic)(4.36)(4.69)(3.42)(1.59)(1.65)
EPS (Diluted)(4.36)(4.69)(3.42)(1.59)(1.65)
Weighted Avg Shares3.95M4.73M5.52M7.48M8.48M
Weighted Avg Shares (Diluted)3.95M4.73M5.52M7.48M8.48M

electroCore, Inc.

NASDAQ:ECOR

Intrinsic Alpha fair value

Locked

Current Price

$7.71

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.